Result page for
Withdrawn ID 408:
Molindone

General information:
Withdrawal information:
| Withdrawn due to drug safety reasons: | No |
| First approved: |
1974 |
Side-effects:
| Total reported cases (submitted by medical professionals)
with Molindone as primary suspect: |
3 |
Reported final outcomes:
| Disability: |
1 |
| Intervention required to
prevent permanent impairment/damage: |
1 |
| Hospitalization (initial or prolonged): |
1 |
Reported side-effects:
| Side-effect |
Case number |
| PYREXIA | 1 |
| NYSTAGMUS | 1 |
| MUSCULOSKELETAL STIFFNESS | 1 |
| Hypersensitivity | 1 |
| DYSTONIA | 1 |
Filtered ChEMBL targets:
| Target UniProtKB ID |
Activity in nm |
Target Name |
Target gene |
| P34969 |
265 |
5-hydroxytryptamine receptor 7 |
5HT7R_HUMAN |
Toxicity information:
|
Toxicity class: |
3 |
| Toxicity type: |
N/A |
| LD50: |
220 mg/kg |
External links: